Nonextraction testosterone immunoassays of samples from women are nonspecific because of interference by closely related steroids (1 ) . The reference method, isotope-dilution GC-MS is not suitable for routine use. LC-MS is increasingly being used with women because of its enhanced specificity (2 ) . Not all routine laboratories have access to LC-MS.
Dehydroepiandrosterone sulfate (DHEAS) interferes in several testosterone immunoassays, including the Roche Testosterone immunoassay (3 ) . Roche claims that their Testosterone II immunoassay improves testosterone measurement in women, with reduced DHEAS interference. Some characteristics of this assay have been published (4 ). The claim that this assay is prone to less DHEAS interference has not been independently verified. The LC-MS method for testosterone was developed in house with deuterated testosterone used as internal standard. Ten microliters of internal standard was added to 200 L containing sample, calibrator, and QC material in a 2.0-mL microtube containing 1 mL methyl tert-butyl ether and mixed for 10 min. The separated solvent was evaporated under nitrogen, and the sample was reconstituted in 100 L of a solvent consisting of equal volumes of water and methanol. The sample was then transferred to a 96-well plate, heat-sealed, and loaded onto the autosampler. Chromatography was performed with a Waters 2795 HPLC system. Fifty microliters of the extracted sample was injected at 24°C onto a SecurityGuard C18 column (4 mm ϫ 2 mm; Phenomenex), which was connected to a Synergi™ 4-m Hydro-RP column (50 mm ϫ 3 mm; Phenomenex). The initial mobile phase was 700 mL/L methanol for 2 min. That was followed by 950 mL/L methanol mobile phase for 0.5 min before reequilibration with starting conditions for 1 min. The flow rate was 0.6 mL/min. The eluted sample was pumped directly to the electrospray probe of the mass spectrometer (Waters Quattro micro tandem mass spectrometer) without splitting or solvent diversion, in electrospray positive-ionization mode, and with multiple reaction monitoring mode. The total run time was 4.3 min. The process control used Waters MassLynx NT 4.1 software, and data processing used the MassLynx Quantify program. The LC-MS assay was validated according to US Food and Drug Administration guidance (5 ). The lower limit of quantification was 7.2 ng/dL (0.25 nmol/L) (CV, 15%) with good linearity, recovery (96%-100%), and precision. Intra-and interassay CVs were 5.4%-14% and 6.4%-15%, respectively. There was no ion suppression.
The testosterone immunoassays were compared to each other and to LC-MS. The correlation between the 2 The testosterone concentrations for both immunoassays were positively correlated with the DHEAS concentration (Testosterone, r 2 ϭ 0.73; Testosterone II, r 2 ϭ 0.63), and the difference between the 2 immunoassays was positively related to the measured DHEAS concentration (r 2 ϭ 0.38). The LC-MS assay is less strongly correlated with the DHEAS concentration (r 2 ϭ 0.23). The difference between each individual testosterone immunoassay result and the LC-MS result (i.e., immunoassay minus LC-MS) was examined. The results for the Testosterone immunoassay showed a stronger relationship with DHEAS (r 2 ϭ 0.72) than those for the Testosterone II immunoassay (r 2 ϭ 0.45) (Fig. 1) .
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